| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 6.26e-08 | 276 | 27 | 7 | GO:0003730 | |
| GeneOntologyMolecularFunction | G-rich strand telomeric DNA binding | 3.61e-07 | 11 | 27 | 3 | GO:0098505 | |
| GeneOntologyMolecularFunction | single-stranded telomeric DNA binding | 6.25e-07 | 13 | 27 | 3 | GO:0043047 | |
| GeneOntologyMolecularFunction | sequence-specific single stranded DNA binding | 9.92e-07 | 15 | 27 | 3 | GO:0098847 | |
| GeneOntologyMolecularFunction | pre-mRNA binding | 1.59e-06 | 64 | 27 | 4 | GO:0036002 | |
| GeneOntologyMolecularFunction | telomeric repeat-containing RNA binding | 5.28e-06 | 3 | 27 | 2 | GO:0061752 | |
| GeneOntologyMolecularFunction | RNA strand annealing activity | 1.76e-05 | 5 | 27 | 2 | GO:0033592 | |
| GeneOntologyMolecularFunction | telomeric DNA binding | 2.11e-05 | 40 | 27 | 3 | GO:0042162 | |
| GeneOntologyMolecularFunction | mRNA binding | 2.87e-05 | 694 | 27 | 7 | GO:0003729 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 3.02e-05 | 134 | 27 | 4 | GO:0003697 | |
| GeneOntologyMolecularFunction | miRNA binding | 3.66e-05 | 48 | 27 | 3 | GO:0035198 | |
| GeneOntologyMolecularFunction | regulatory RNA binding | 7.91e-05 | 62 | 27 | 3 | GO:0061980 | |
| GeneOntologyMolecularFunction | DNA/DNA annealing activity | 9.61e-05 | 11 | 27 | 2 | GO:1990814 | |
| GeneOntologyMolecularFunction | annealing activity | 1.59e-04 | 14 | 27 | 2 | GO:0140666 | |
| GeneOntologyMolecularFunction | sequence-specific mRNA binding | 2.97e-04 | 19 | 27 | 2 | GO:1990825 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 4.44e-04 | 111 | 27 | 3 | GO:0003727 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 4.77e-04 | 24 | 27 | 2 | GO:0140517 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 3.91e-03 | 1160 | 27 | 6 | GO:0030674 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 5.77e-03 | 875 | 27 | 5 | GO:0019904 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 8.34e-03 | 1356 | 27 | 6 | GO:0060090 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 4.50e-06 | 358 | 26 | 6 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 4.50e-06 | 358 | 26 | 6 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 4.80e-06 | 362 | 26 | 6 | GO:0000375 | |
| GeneOntologyBiologicalProcess | RNA localization | 6.76e-06 | 217 | 26 | 5 | GO:0006403 | |
| GeneOntologyBiologicalProcess | RNA splicing | 3.07e-05 | 502 | 26 | 6 | GO:0008380 | |
| GeneOntologyBiologicalProcess | mRNA transport | 3.11e-05 | 145 | 26 | 4 | GO:0051028 | |
| GeneOntologyBiologicalProcess | mRNA processing | 5.16e-05 | 551 | 26 | 6 | GO:0006397 | |
| GeneOntologyBiologicalProcess | RNA transport | 6.47e-05 | 175 | 26 | 4 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 6.47e-05 | 175 | 26 | 4 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 6.91e-05 | 178 | 26 | 4 | GO:0051236 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomere lengthening | 8.82e-05 | 69 | 26 | 3 | GO:1904356 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 1.32e-04 | 79 | 26 | 3 | GO:0000380 | |
| GeneOntologyBiologicalProcess | cellular response to potassium ion | 1.38e-04 | 14 | 26 | 2 | GO:0035865 | |
| GeneOntologyBiologicalProcess | regulation of action potential | 1.42e-04 | 81 | 26 | 3 | GO:0098900 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomere lengthening | 1.94e-04 | 90 | 26 | 3 | GO:0010833 | |
| GeneOntologyBiologicalProcess | positive regulation of action potential | 2.31e-04 | 18 | 26 | 2 | GO:0045760 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 2.51e-04 | 249 | 26 | 4 | GO:0015931 | |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 2.86e-04 | 20 | 26 | 2 | GO:0003184 | |
| GeneOntologyBiologicalProcess | response to potassium ion | 3.16e-04 | 21 | 26 | 2 | GO:0035864 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance | 3.70e-04 | 112 | 26 | 3 | GO:0032204 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 4.15e-04 | 24 | 26 | 2 | GO:0003177 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance via telomerase | 4.50e-04 | 25 | 26 | 2 | GO:0032211 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 5.59e-04 | 129 | 26 | 3 | GO:0048024 | |
| GeneOntologyBiologicalProcess | regulation of DNA biosynthetic process | 6.81e-04 | 138 | 26 | 3 | GO:2000278 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance via telomere lengthening | 7.88e-04 | 33 | 26 | 2 | GO:1904357 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 8.14e-04 | 917 | 26 | 6 | GO:0016071 | |
| GeneOntologyBiologicalProcess | regulation of neuron apoptotic process | 9.56e-04 | 355 | 26 | 4 | GO:0043523 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 1.01e-03 | 158 | 26 | 3 | GO:0050684 | |
| GeneOntologyBiologicalProcess | positive regulation of telomere maintenance via telomere lengthening | 1.10e-03 | 39 | 26 | 2 | GO:1904358 | |
| GeneOntologyBiologicalProcess | telomere maintenance | 1.20e-03 | 168 | 26 | 3 | GO:0000723 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance | 1.28e-03 | 42 | 26 | 2 | GO:0032205 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA biosynthetic process | 1.34e-03 | 43 | 26 | 2 | GO:2000279 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 2.34e-09 | 97 | 27 | 6 | GO:0071013 | |
| GeneOntologyCellularComponent | spliceosomal complex | 2.73e-07 | 215 | 27 | 6 | GO:0005681 | |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 2.40e-05 | 6 | 27 | 2 | GO:1990826 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | HNRNPA1L2 TIAL1 RBM45 HNRNPA1 HNRNPA1L3 HNRNPA2B1 HNRNPU HNRNPA3 | 9.25e-05 | 1194 | 27 | 8 | GO:1990904 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | BCL9L HNRNPA1L2 HNRNPA1 HNRNPA1L3 HNRNPA2B1 CHD5 HNRNPU HNRNPA3 | 2.49e-04 | 1377 | 27 | 8 | GO:0140513 |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 4.76e-04 | 287 | 27 | 4 | GO:0035770 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 5.12e-04 | 817 | 27 | 6 | GO:0098978 | |
| GeneOntologyCellularComponent | postsynapse | 1.61e-03 | 1018 | 27 | 6 | GO:0098794 | |
| GeneOntologyCellularComponent | asymmetric synapse | 3.10e-03 | 477 | 27 | 4 | GO:0032279 | |
| GeneOntologyCellularComponent | cytosolic region | 3.68e-03 | 70 | 27 | 2 | GO:0099522 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 4.14e-03 | 1228 | 27 | 6 | GO:0036477 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 4.30e-03 | 523 | 27 | 4 | GO:0098984 | |
| GeneOntologyCellularComponent | dendrite | 4.38e-03 | 858 | 27 | 5 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 4.42e-03 | 860 | 27 | 5 | GO:0097447 | |
| HumanPheno | Ubiquitin-positive cerebral inclusion bodies | 2.10e-05 | 3 | 14 | 2 | HP:0012083 | |
| HumanPheno | EMG: chronic denervation signs | 5.20e-05 | 28 | 14 | 3 | HP:0003444 | |
| MousePheno | tongue muscle hypoplasia | 2.82e-06 | 2 | 24 | 2 | MP:0030421 | |
| MousePheno | abnormal P wave | 8.79e-06 | 24 | 24 | 3 | MP:0004070 | |
| MousePheno | skeletal muscle hypoplasia | 2.82e-05 | 5 | 24 | 2 | MP:0009460 | |
| MousePheno | abnormal sinoatrial node conduction | 4.89e-05 | 42 | 24 | 3 | MP:0006142 | |
| MousePheno | dilated cardiomyopathy | 1.43e-04 | 60 | 24 | 3 | MP:0002795 | |
| MousePheno | abnormal PR interval | 1.81e-04 | 65 | 24 | 3 | MP:0003901 | |
| MousePheno | abnormal intercostal muscle morphology | 2.93e-04 | 15 | 24 | 2 | MP:0002280 | |
| MousePheno | muscle hypoplasia | 2.93e-04 | 15 | 24 | 2 | MP:0000734 | |
| MousePheno | abnormal tongue muscle morphology | 3.34e-04 | 16 | 24 | 2 | MP:0004136 | |
| MousePheno | abnormal atrioventricular node conduction | 3.73e-04 | 83 | 24 | 3 | MP:0006141 | |
| MousePheno | retina ganglion cell degeneration | 4.75e-04 | 19 | 24 | 2 | MP:0008067 | |
| MousePheno | shortened PR interval | 6.99e-04 | 23 | 24 | 2 | MP:0010511 | |
| MousePheno | abnormal urinary bladder morphology | 7.65e-04 | 247 | 24 | 4 | MP:0000538 | |
| MousePheno | cardiomyopathy | 8.28e-04 | 109 | 24 | 3 | MP:0005330 | |
| MousePheno | increased heart rate | 1.09e-03 | 120 | 24 | 3 | MP:0002626 | |
| Domain | HnRNPA1 | 2.12e-09 | 3 | 25 | 3 | PF11627 | |
| Domain | HnRNPA1 | 2.12e-09 | 3 | 25 | 3 | IPR021662 | |
| Domain | RRM_1 | 2.63e-07 | 208 | 25 | 6 | PF00076 | |
| Domain | RRM | 3.38e-07 | 217 | 25 | 6 | SM00360 | |
| Domain | RRM_dom | 4.40e-07 | 227 | 25 | 6 | IPR000504 | |
| Domain | RRM | 4.76e-07 | 230 | 25 | 6 | PS50102 | |
| Domain | - | 6.72e-07 | 244 | 25 | 6 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 9.31e-07 | 258 | 25 | 6 | IPR012677 | |
| Domain | DEP_dom | 4.28e-04 | 23 | 25 | 2 | IPR000591 | |
| Pathway | WP_MRNA_PROCESSING | 5.15e-06 | 451 | 23 | 7 | MM15946 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.53e-05 | 201 | 23 | 5 | MM15411 | |
| Pathway | KEGG_SPLICEOSOME | 4.87e-05 | 127 | 23 | 4 | M2044 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 7.11e-05 | 277 | 23 | 5 | MM15414 | |
| Pathway | REACTOME_MRNA_SPLICING | 3.52e-04 | 212 | 23 | 4 | M14033 | |
| Pathway | REACTOME_FGFR2_ALTERNATIVE_SPLICING | 3.83e-04 | 18 | 23 | 2 | MM15334 | |
| Pathway | REACTOME_FGFR2_ALTERNATIVE_SPLICING | 8.72e-04 | 27 | 23 | 2 | M27632 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.04e-03 | 283 | 23 | 4 | M13087 | |
| Pathway | WP_MRNA_PROCESSING | 1.08e-03 | 126 | 23 | 3 | M39406 | |
| Pathway | REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION | 1.73e-03 | 38 | 23 | 2 | M27820 | |
| Pathway | REACTOME_INTERLEUKIN_12_SIGNALING | 2.63e-03 | 47 | 23 | 2 | M27894 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 2.66e-03 | 612 | 23 | 5 | MM15547 | |
| Pubmed | 4.97e-12 | 22 | 27 | 5 | 12456657 | ||
| Pubmed | 2.87e-10 | 14 | 27 | 4 | 24553115 | ||
| Pubmed | Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis. | 4.17e-10 | 3 | 27 | 3 | 23827524 | |
| Pubmed | A widespread sequence-specific mRNA decay pathway mediated by hnRNPs A1 and A2/B1. | 4.17e-10 | 3 | 27 | 3 | 27151978 | |
| Pubmed | 4.83e-10 | 52 | 27 | 5 | 26265008 | ||
| Pubmed | Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch. | 1.67e-09 | 4 | 27 | 3 | 12426391 | |
| Pubmed | ALS-linked mutations in ubiquilin-2 or hnRNPA1 reduce interaction between ubiquilin-2 and hnRNPA1. | 1.67e-09 | 4 | 27 | 3 | 25616961 | |
| Pubmed | 4.17e-09 | 5 | 27 | 3 | 20133837 | ||
| Pubmed | HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy. | 1.46e-08 | 7 | 27 | 3 | 32086392 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 4.08e-08 | 258 | 27 | 6 | 37794589 | |
| Pubmed | 6.40e-08 | 136 | 27 | 5 | 26979993 | ||
| Pubmed | The biogenesis of the coiled body during early mouse development. | 9.14e-08 | 12 | 27 | 3 | 7768196 | |
| Pubmed | Regulation of alternative splicing by SRrp86 and its interacting proteins. | 1.11e-07 | 57 | 27 | 4 | 14559993 | |
| Pubmed | IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. | 1.19e-07 | 58 | 27 | 4 | 21642987 | |
| Pubmed | 2.06e-07 | 172 | 27 | 5 | 26336360 | ||
| Pubmed | BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites. | 3.02e-07 | 73 | 27 | 4 | 32347575 | |
| Pubmed | 4.37e-07 | 80 | 27 | 4 | 11991638 | ||
| Pubmed | Germline Chd8 haploinsufficiency alters brain development in mouse. | 4.71e-07 | 20 | 27 | 3 | 28671691 | |
| Pubmed | Quantitative analysis of PPT1 interactome in human neuroblastoma cells. | 5.54e-07 | 210 | 27 | 5 | 26217791 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 32960212 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 24612671 | ||
| Pubmed | siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference. | 5.80e-07 | 2 | 27 | 2 | 15215364 | |
| Pubmed | Phosphorylation of hnRNP A1-Serine 199 Is Not Required for T Cell Differentiation and Function. | 5.80e-07 | 2 | 27 | 2 | 38334757 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 22628224 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 1406633 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 24119545 | ||
| Pubmed | A Function for the hnRNP A1/A2 Proteins in Transcription Elongation. | 5.80e-07 | 2 | 27 | 2 | 26011126 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 32759322 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 28220845 | ||
| Pubmed | Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. | 5.80e-07 | 2 | 27 | 2 | 23455423 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 31169879 | ||
| Pubmed | Regulation of mouse hepatitis virus RNA synthesis by heterogeneous nuclear ribonucleoprotein A1. | 5.80e-07 | 2 | 27 | 2 | 11774503 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 11774505 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 28912364 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 8041722 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 12060656 | ||
| Pubmed | hnRNP A1 dysfunction in oligodendrocytes contributes to the pathogenesis of multiple sclerosis. | 5.80e-07 | 2 | 27 | 2 | 36382566 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 12560094 | ||
| Pubmed | 5.81e-07 | 212 | 27 | 5 | 23463506 | ||
| Pubmed | 6.42e-07 | 88 | 27 | 4 | 26318153 | ||
| Pubmed | 7.25e-07 | 421 | 27 | 6 | 34650049 | ||
| Pubmed | 8.35e-07 | 24 | 27 | 3 | 30719818 | ||
| Pubmed | Modification of the base excision repair enzyme MBD4 by the small ubiquitin-like molecule SUMO1. | 8.35e-07 | 24 | 27 | 3 | 31476572 | |
| Pubmed | 8.37e-07 | 94 | 27 | 4 | 36584595 | ||
| Pubmed | 8.37e-07 | 94 | 27 | 4 | 35122331 | ||
| Pubmed | 8.68e-07 | 707 | 27 | 7 | 19738201 | ||
| Pubmed | A New Cellular Interactome of SARS-CoV-2 Nucleocapsid Protein and Its Biological Implications. | 8.74e-07 | 95 | 27 | 4 | 37211047 | |
| Pubmed | Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. | 9.11e-07 | 96 | 27 | 4 | 25948554 | |
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 9.90e-07 | 98 | 27 | 4 | 21942715 | |
| Pubmed | 1.05e-06 | 239 | 27 | 5 | 26641092 | ||
| Pubmed | 1.16e-06 | 244 | 27 | 5 | 29884807 | ||
| Pubmed | 1.18e-06 | 245 | 27 | 5 | 21182205 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 1.24e-06 | 462 | 27 | 6 | 31138677 | |
| Pubmed | TERRA transcripts are bound by a complex array of RNA-binding proteins. | 1.35e-06 | 28 | 27 | 3 | 20975687 | |
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | 1.41e-06 | 254 | 27 | 5 | 28431233 | |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | 1.47e-06 | 256 | 27 | 5 | 24189400 | |
| Pubmed | 1.52e-06 | 109 | 27 | 4 | 12226669 | ||
| Pubmed | 1.52e-06 | 109 | 27 | 4 | 29511296 | ||
| Pubmed | Muscle developmental defects in heterogeneous nuclear Ribonucleoprotein A1 knockout mice. | 1.67e-06 | 30 | 27 | 3 | 28077597 | |
| Pubmed | Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. | 1.67e-06 | 30 | 27 | 3 | 15782174 | |
| Pubmed | 1.69e-06 | 112 | 27 | 4 | 28416769 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 25901972 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 21454539 | ||
| Pubmed | The Splicing Factor hnRNPA1 Regulates Alternate Splicing of the MYLK Gene. | 1.74e-06 | 3 | 27 | 2 | 29077485 | |
| Pubmed | Molecular cloning of the genes suppressed in RVC lymphoma cells by topoisomerase inhibitors. | 1.74e-06 | 3 | 27 | 2 | 8912629 | |
| Pubmed | PRMT5 regulates IRES-dependent translation via methylation of hnRNP A1. | 1.74e-06 | 3 | 27 | 2 | 28115626 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 28088441 | ||
| Pubmed | eIF2alpha phosphorylation tips the balance to apoptosis during osmotic stress. | 1.74e-06 | 3 | 27 | 2 | 20338999 | |
| Pubmed | Inclusion Body Myopathy with Paget Disease of Bone and/or Frontotemporal Dementia | 1.74e-06 | 3 | 27 | 2 | 20301649 | |
| Pubmed | Quaking regulates Hnrnpa1 expression through its 3' UTR in oligodendrocyte precursor cells. | 1.74e-06 | 3 | 27 | 2 | 21253564 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 33115498 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 38320300 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 37525910 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 19008955 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 27595546 | ||
| Pubmed | Differential effects of hnRNP D/AUF1 isoforms on HIV-1 gene expression. | 1.74e-06 | 3 | 27 | 2 | 22187150 | |
| Pubmed | HuR-regulated mRNAs associated with nuclear hnRNP A1-RNP complexes. | 1.74e-06 | 3 | 27 | 2 | 24152440 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 15390079 | ||
| Pubmed | hnRNP A1 and secondary structure coordinate alternative splicing of Mag. | 1.74e-06 | 3 | 27 | 2 | 23704325 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 31311954 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 33692334 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 23658645 | ||
| Pubmed | The RGG domain in hnRNP A2 affects subcellular localization. | 1.74e-06 | 3 | 27 | 2 | 10772824 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 23946460 | ||
| Pubmed | 1.88e-06 | 115 | 27 | 4 | 17332742 | ||
| Pubmed | Viral immune modulators perturb the human molecular network by common and unique strategies. | 1.94e-06 | 116 | 27 | 4 | 22810585 | |
| Pubmed | Proteomic analysis of complexes formed by human topoisomerase I. | 2.04e-06 | 32 | 27 | 3 | 15848144 | |
| Pubmed | 2.04e-06 | 32 | 27 | 3 | 21853274 | ||
| Pubmed | 2.45e-06 | 123 | 27 | 4 | 35583604 | ||
| Pubmed | Cdc37 interacts with the glycine-rich loop of Hsp90 client kinases. | 2.46e-06 | 34 | 27 | 3 | 16611982 | |
| Pubmed | 2.93e-06 | 36 | 27 | 3 | 17289661 | ||
| Pubmed | 3.47e-06 | 552 | 27 | 6 | 36293380 | ||
| Pubmed | HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. | 3.48e-06 | 4 | 27 | 2 | 20010808 | |
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 22345078 | ||
| Pubmed | Analysis of RNA-protein interactions of mouse liver cytochrome P4502A5 mRNA. | 3.48e-06 | 4 | 27 | 2 | 10215609 | |
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 34944075 | ||
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 33951764 | ||
| Pubmed | Nuclear TDP-43 causes neuronal toxicity by escaping from the inhibitory regulation by hnRNPs. | 3.48e-06 | 4 | 27 | 2 | 25378556 | |
| Pubmed | HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy. | 3.48e-06 | 4 | 27 | 2 | 12945950 | |
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 29396485 | ||
| Interaction | FCMR interactions | 7.14e-10 | 11 | 26 | 4 | int:FCMR | |
| Interaction | EPX interactions | 3.92e-09 | 16 | 26 | 4 | int:EPX | |
| Interaction | G6PC2 interactions | 7.62e-09 | 4 | 26 | 3 | int:G6PC2 | |
| Interaction | OR9Q2 interactions | 1.90e-08 | 5 | 26 | 3 | int:OR9Q2 | |
| Interaction | HNRNPA1L2 interactions | 3.26e-08 | 151 | 26 | 6 | int:HNRNPA1L2 | |
| Interaction | NAA20 interactions | 6.69e-08 | 31 | 26 | 4 | int:NAA20 | |
| Interaction | HNRNPH3 interactions | 7.97e-08 | 301 | 26 | 7 | int:HNRNPH3 | |
| Interaction | MIR29A interactions | 8.17e-08 | 87 | 26 | 5 | int:MIR29A | |
| Interaction | DNAH2 interactions | 9.83e-08 | 34 | 26 | 4 | int:DNAH2 | |
| Interaction | HNRNPH2 interactions | 1.02e-07 | 312 | 26 | 7 | int:HNRNPH2 | |
| Interaction | C2orf78 interactions | 1.06e-07 | 8 | 26 | 3 | int:C2orf78 | |
| Interaction | DNAH6 interactions | 1.25e-07 | 36 | 26 | 4 | int:DNAH6 | |
| Interaction | PABPC1 interactions | TIAL1 PPT1 RBM45 SMAP2 HNRNPA1 HNRNPA2B1 HNRNPU HNRNPA3 CRY1 | 1.27e-07 | 699 | 26 | 9 | int:PABPC1 |
| Interaction | ANKRD12 interactions | 1.40e-07 | 37 | 26 | 4 | int:ANKRD12 | |
| Interaction | HNRNPAB interactions | 3.29e-07 | 371 | 26 | 7 | int:HNRNPAB | |
| Interaction | UBQLN2 interactions | SCYL2 TIAL1 ABI2 SMAP2 HNRNPA1 HNRNPA2B1 CNN2 HNRNPU HNRNPA3 | 3.86e-07 | 797 | 26 | 9 | int:UBQLN2 |
| Interaction | SNRPD3 interactions | 3.87e-07 | 380 | 26 | 7 | int:SNRPD3 | |
| Interaction | HNRNPF interactions | 6.25e-07 | 607 | 26 | 8 | int:HNRNPF | |
| Interaction | DAZL interactions | 1.05e-06 | 145 | 26 | 5 | int:DAZL | |
| Interaction | MATR3 interactions | 1.11e-06 | 655 | 26 | 8 | int:MATR3 | |
| Interaction | PCBP1 interactions | 1.33e-06 | 671 | 26 | 8 | int:PCBP1 | |
| Interaction | CELF1 interactions | 1.46e-06 | 288 | 26 | 6 | int:CELF1 | |
| Interaction | CRY1 interactions | 1.81e-06 | 162 | 26 | 5 | int:CRY1 | |
| Interaction | MIR20A interactions | 2.35e-06 | 74 | 26 | 4 | int:MIR20A | |
| Interaction | BGLT3 interactions | 2.49e-06 | 75 | 26 | 4 | int:BGLT3 | |
| Interaction | MIR9-2 interactions | 2.76e-06 | 77 | 26 | 4 | int:MIR9-2 | |
| Interaction | MIR200A interactions | 2.76e-06 | 77 | 26 | 4 | int:MIR200A | |
| Interaction | HNRNPA3 interactions | 2.80e-06 | 511 | 26 | 7 | int:HNRNPA3 | |
| Interaction | IFIT3 interactions | 3.22e-06 | 80 | 26 | 4 | int:IFIT3 | |
| Interaction | MIR145 interactions | 3.38e-06 | 81 | 26 | 4 | int:MIR145 | |
| Interaction | MIR106A interactions | 3.73e-06 | 83 | 26 | 4 | int:MIR106A | |
| Interaction | TNF interactions | 3.82e-06 | 340 | 26 | 6 | int:TNF | |
| Interaction | MIR199A1 interactions | 3.91e-06 | 84 | 26 | 4 | int:MIR199A1 | |
| Interaction | HNRNPA0 interactions | 4.44e-06 | 349 | 26 | 6 | int:HNRNPA0 | |
| Interaction | MIR29C interactions | 4.93e-06 | 89 | 26 | 4 | int:MIR29C | |
| Interaction | HNRNPDL interactions | 5.65e-06 | 364 | 26 | 6 | int:HNRNPDL | |
| Interaction | MIR205 interactions | 5.88e-06 | 93 | 26 | 4 | int:MIR205 | |
| Interaction | RBM45 interactions | 6.01e-06 | 207 | 26 | 5 | int:RBM45 | |
| Interaction | EEF2 interactions | 7.05e-06 | 588 | 26 | 7 | int:EEF2 | |
| Interaction | MIR106B interactions | 7.24e-06 | 98 | 26 | 4 | int:MIR106B | |
| Interaction | HNRNPK interactions | 7.89e-06 | 853 | 26 | 8 | int:HNRNPK | |
| Interaction | MIR25 interactions | 8.16e-06 | 101 | 26 | 4 | int:MIR25 | |
| Interaction | MIR15B interactions | 8.82e-06 | 103 | 26 | 4 | int:MIR15B | |
| Interaction | MIR34A interactions | 9.17e-06 | 104 | 26 | 4 | int:MIR34A | |
| Interaction | TSPYL2 interactions | 9.52e-06 | 105 | 26 | 4 | int:TSPYL2 | |
| Interaction | CCDC178 interactions | 9.59e-06 | 4 | 26 | 2 | int:CCDC178 | |
| Interaction | MIR34B interactions | 1.14e-05 | 110 | 26 | 4 | int:MIR34B | |
| Interaction | IGSF8 interactions | 1.21e-05 | 239 | 26 | 5 | int:IGSF8 | |
| Interaction | STARD9 interactions | 1.56e-05 | 38 | 26 | 3 | int:STARD9 | |
| Interaction | PTBP1 interactions | 1.60e-05 | 437 | 26 | 6 | int:PTBP1 | |
| Interaction | PPT1 interactions | 1.68e-05 | 256 | 26 | 5 | int:PPT1 | |
| Interaction | PABPC4 interactions | 1.71e-05 | 442 | 26 | 6 | int:PABPC4 | |
| Interaction | MTF1 interactions | 1.78e-05 | 123 | 26 | 4 | int:MTF1 | |
| Interaction | ZNF35 interactions | 1.97e-05 | 41 | 26 | 3 | int:ZNF35 | |
| Interaction | TRIM31 interactions | 1.99e-05 | 454 | 26 | 6 | int:TRIM31 | |
| Interaction | PNO1 interactions | 2.15e-05 | 129 | 26 | 4 | int:PNO1 | |
| Interaction | DCUN1D1 interactions | 2.37e-05 | 275 | 26 | 5 | int:DCUN1D1 | |
| Interaction | VCAM1 interactions | 2.56e-05 | 475 | 26 | 6 | int:VCAM1 | |
| Interaction | PCBP2 interactions | 2.96e-05 | 288 | 26 | 5 | int:PCBP2 | |
| Interaction | HNRNPU interactions | 3.21e-05 | 1035 | 26 | 8 | int:HNRNPU | |
| Interaction | EIF4A3 interactions | 3.38e-05 | 499 | 26 | 6 | int:EIF4A3 | |
| Interaction | HNRNPA2B1 interactions | 3.52e-05 | 754 | 26 | 7 | int:HNRNPA2B1 | |
| Interaction | PPIL1 interactions | 3.59e-05 | 147 | 26 | 4 | int:PPIL1 | |
| Interaction | CD81 interactions | 3.77e-05 | 303 | 26 | 5 | int:CD81 | |
| Interaction | FUBP1 interactions | 4.14e-05 | 309 | 26 | 5 | int:FUBP1 | |
| Interaction | PER2 interactions | 4.19e-05 | 153 | 26 | 4 | int:PER2 | |
| Interaction | TARDBP interactions | 4.25e-05 | 520 | 26 | 6 | int:TARDBP | |
| Interaction | ACTB interactions | 4.44e-05 | 1083 | 26 | 8 | int:ACTB | |
| Interaction | SNAI1 interactions | 5.58e-05 | 546 | 26 | 6 | int:SNAI1 | |
| Interaction | RBM42 interactions | 5.74e-05 | 331 | 26 | 5 | int:RBM42 | |
| Interaction | SFPQ interactions | 6.62e-05 | 563 | 26 | 6 | int:SFPQ | |
| Interaction | SNRPD1 interactions | 7.18e-05 | 347 | 26 | 5 | int:SNRPD1 | |
| Interaction | FN1 interactions | 7.43e-05 | 848 | 26 | 7 | int:FN1 | |
| Interaction | UPF1 interactions | 7.87e-05 | 581 | 26 | 6 | int:UPF1 | |
| Interaction | IGF2BP2 interactions | 8.21e-05 | 357 | 26 | 5 | int:IGF2BP2 | |
| Interaction | SSBP1 interactions | 8.41e-05 | 588 | 26 | 6 | int:SSBP1 | |
| Interaction | SREK1 interactions | 8.41e-05 | 183 | 26 | 4 | int:SREK1 | |
| Interaction | WDR77 interactions | 8.66e-05 | 361 | 26 | 5 | int:WDR77 | |
| Interaction | MIR138-1 interactions | 9.04e-05 | 68 | 26 | 3 | int:MIR138-1 | |
| Interaction | MIR9-3 interactions | 9.85e-05 | 70 | 26 | 3 | int:MIR9-3 | |
| Interaction | KRT14 interactions | 1.01e-04 | 192 | 26 | 4 | int:KRT14 | |
| Interaction | PABPN1 interactions | 1.01e-04 | 192 | 26 | 4 | int:PABPN1 | |
| Interaction | MIR29B2 interactions | 1.03e-04 | 71 | 26 | 3 | int:MIR29B2 | |
| Interaction | MIR140 interactions | 1.03e-04 | 71 | 26 | 3 | int:MIR140 | |
| Interaction | MIR122 interactions | 1.03e-04 | 71 | 26 | 3 | int:MIR122 | |
| Interaction | CAND1 interactions | 1.04e-04 | 894 | 26 | 7 | int:CAND1 | |
| Interaction | SAMD9L interactions | 1.05e-04 | 12 | 26 | 2 | int:SAMD9L | |
| Interaction | OBSL1 interactions | 1.09e-04 | 902 | 26 | 7 | int:OBSL1 | |
| Interaction | MIR29B1 interactions | 1.12e-04 | 73 | 26 | 3 | int:MIR29B1 | |
| Interaction | MIR18A interactions | 1.12e-04 | 73 | 26 | 3 | int:MIR18A | |
| Interaction | GGCT interactions | 1.12e-04 | 73 | 26 | 3 | int:GGCT | |
| Interaction | NSRP1 interactions | 1.12e-04 | 197 | 26 | 4 | int:NSRP1 | |
| Interaction | MIR15A interactions | 1.21e-04 | 75 | 26 | 3 | int:MIR15A | |
| Interaction | MIR16-1 interactions | 1.26e-04 | 76 | 26 | 3 | int:MIR16-1 | |
| Interaction | MIR199A2 interactions | 1.26e-04 | 76 | 26 | 3 | int:MIR199A2 | |
| Interaction | MIR429 interactions | 1.26e-04 | 76 | 26 | 3 | int:MIR429 | |
| Interaction | MIR7-3 interactions | 1.26e-04 | 76 | 26 | 3 | int:MIR7-3 | |
| Interaction | HNRNPC interactions | 1.27e-04 | 634 | 26 | 6 | int:HNRNPC | |
| Interaction | NEDD8 interactions | 1.29e-04 | 393 | 26 | 5 | int:NEDD8 | |
| Interaction | HNRNPD interactions | 1.32e-04 | 638 | 26 | 6 | int:HNRNPD | |
| Cytoband | 3p12.3 | 5.07e-05 | 18 | 27 | 2 | 3p12.3 | |
| Cytoband | 2q31.2 | 6.95e-05 | 21 | 27 | 2 | 2q31.2 | |
| Cytoband | 1q43 | 4.17e-04 | 51 | 27 | 2 | 1q43 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q43 | 6.16e-04 | 62 | 27 | 2 | chr1q43 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 6.79e-04 | 294 | 27 | 3 | chr1p34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p12 | 8.53e-04 | 73 | 27 | 2 | chr3p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q23 | 3.53e-03 | 150 | 27 | 2 | chr12q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q31 | 4.92e-03 | 178 | 27 | 2 | chr2q31 | |
| GeneFamily | RNA binding motif containing | 4.11e-08 | 213 | 18 | 6 | 725 | |
| Coexpression | GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN | 1.73e-06 | 200 | 27 | 5 | M9563 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | 5.26e-06 | 448 | 27 | 6 | MM1044 | |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | 3.87e-05 | 380 | 27 | 5 | M41703 | |
| Coexpression | GSE5960_TH1_VS_ANERGIC_TH1_UP | 4.93e-05 | 199 | 27 | 4 | M5637 | |
| Coexpression | HALLMARK_MYC_TARGETS_V1 | 5.03e-05 | 200 | 27 | 4 | M5926 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.75e-05 | 129 | 26 | 4 | gudmap_developingKidney_e14.5 whole kidney - wildtype_1000_k3 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 1.14e-07 | 197 | 27 | 5 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.71e-06 | 187 | 27 | 4 | 173f029dcf32af008f517912f6d110a33a9e98cf | |
| ToppCell | HSPCs-Ery/Mk_prog.|World / Lineage and Cell class | 4.81e-06 | 188 | 27 | 4 | 5390089213cd6ee90dcdfd3c3f5b6765376cccf2 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.01e-06 | 190 | 27 | 4 | c01a8bfb9fbc0e6f37d7e9be25512eda63acabbc | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.78e-06 | 197 | 27 | 4 | c7b33d64e5cba3a8fc6f2d6aa85ebc83893195de | |
| ToppCell | 10x_3'_v3|World / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.90e-06 | 198 | 27 | 4 | aabb8e9b162ae4cb26ea860c99decdbb51e379e1 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.90e-06 | 198 | 27 | 4 | ea6621a148a96c8ffa1a93a35c9e288545d2637a | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 5.90e-06 | 198 | 27 | 4 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.90e-06 | 198 | 27 | 4 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.14e-06 | 200 | 27 | 4 | 4234bdc70a9941d4bf77148d75bd271e0c114b88 | |
| ToppCell | severe|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.14e-06 | 200 | 27 | 4 | accc618d6b960bff30cb531c1226295bfc8650f6 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 6.14e-06 | 200 | 27 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_mature|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.55e-05 | 115 | 27 | 3 | c3f6efb90d5ee01af831f65e240505faa6a71dc0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.11e-05 | 127 | 27 | 3 | 353484362448f27e8377447d0c26391b1da7acc5 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.26e-05 | 128 | 27 | 3 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.40e-05 | 129 | 27 | 3 | a60935ff9c5a841899ccfe90531533ba4c546df3 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.63e-05 | 148 | 27 | 3 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEMP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-04 | 153 | 27 | 3 | 14753baa9980f75206fefc3c8b43685fd4178a43 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.19e-04 | 159 | 27 | 3 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.28e-04 | 163 | 27 | 3 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-4|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.35e-04 | 166 | 27 | 3 | 52293b8a74d46e6161fb6a2e7e86e51fd9e89a5b | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-04 | 176 | 27 | 3 | ce85a13e10cf37f5cf38ca8b0bac6701b6d00ffd | |
| ToppCell | severe-CD8+_T_naive|severe / disease stage, cell group and cell class | 1.72e-04 | 180 | 27 | 3 | 94fe530367b170777f4051a4034cff06d80dbb83 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.77e-04 | 182 | 27 | 3 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.77e-04 | 182 | 27 | 3 | f549b986caebc5eb1b2d12f34fe33087e8324a31 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-04 | 184 | 27 | 3 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 184 | 27 | 3 | 1c857126c0ea0671f0d60b048efca288d348d653 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 186 | 27 | 3 | 11929e36d8c9b4c4bc2f5e912f139f474f91ab00 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 186 | 27 | 3 | 9a7932d0a208f3997216bd21a72913cc82b59fc9 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 188 | 27 | 3 | e0184d9f6687d7ecb8fc461294ff7208f49c437c | |
| ToppCell | Fibroblast-A|World / shred on cell class and cell subclass (v4) | 1.95e-04 | 188 | 27 | 3 | 6740bed5fb8f45b6eea17041894b804214c2a4ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 188 | 27 | 3 | 3cee9916399e2e7580cecbcbb27424a71e7e7ac0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.98e-04 | 189 | 27 | 3 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-04 | 189 | 27 | 3 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.98e-04 | 189 | 27 | 3 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.01e-04 | 190 | 27 | 3 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.01e-04 | 190 | 27 | 3 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.01e-04 | 190 | 27 | 3 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.01e-04 | 190 | 27 | 3 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 2.01e-04 | 190 | 27 | 3 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | E15.5-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.04e-04 | 191 | 27 | 3 | 6f5d91a9583bbb30dfaa30dd9c7772995a9196be | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like-IPCs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.04e-04 | 191 | 27 | 3 | e4c1c533771b582e21683dbec6f93a558d865e00 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-04 | 191 | 27 | 3 | beb5bb42bd53bce01339da9110d374901548793c | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.04e-04 | 191 | 27 | 3 | 48cffb55c71bb8b34e926fc461fcd345ce43ea00 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.04e-04 | 191 | 27 | 3 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-04 | 191 | 27 | 3 | 6609d85fd2577633dcc067507304a6f9e5865ca3 | |
| ToppCell | E15.5-Epithelial-epithelial_progenitor_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.08e-04 | 192 | 27 | 3 | cb6f42dcffe650f7958543531d8f5412b2f2eb12 | |
| ToppCell | PBMC-Control-cDC_4|Control / Compartment, Disease Groups and Clusters | 2.08e-04 | 192 | 27 | 3 | 385061d6257295bd515dea98f9bcd52374509276 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 193 | 27 | 3 | abdfb8b1dbdcb424042e21017a9e829fced4457e | |
| ToppCell | wk_15-18|World / Celltypes from embryonic and fetal-stage human lung | 2.11e-04 | 193 | 27 | 3 | a28ff1e80e3e741739abe869df5fbd41352a1ea0 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-04 | 193 | 27 | 3 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 193 | 27 | 3 | 027e098ad018e782287f84eee0f77551018f2196 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.11e-04 | 193 | 27 | 3 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-04 | 193 | 27 | 3 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 193 | 27 | 3 | c5463a87f20b3a7f7ffda677b2f5a0e9e49d6685 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.14e-04 | 194 | 27 | 3 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.14e-04 | 194 | 27 | 3 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.14e-04 | 194 | 27 | 3 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.14e-04 | 194 | 27 | 3 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | E12.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.14e-04 | 194 | 27 | 3 | 4b335e4da58de1cd94194dc4208ce83854e5e50a | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.14e-04 | 194 | 27 | 3 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.14e-04 | 194 | 27 | 3 | f64da5f62e29253d60b9546edf734ba5c17daae1 | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.14e-04 | 194 | 27 | 3 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.14e-04 | 194 | 27 | 3 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.14e-04 | 194 | 27 | 3 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.14e-04 | 194 | 27 | 3 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-04 | 195 | 27 | 3 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.17e-04 | 195 | 27 | 3 | 79fd13a7dd9f07f86bcab280c0be1899a692fab2 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-04 | 195 | 27 | 3 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-04 | 195 | 27 | 3 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-04 | 195 | 27 | 3 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-04 | 196 | 27 | 3 | fd0a2b863dedaf08d18e7f67da18ac7e853991e4 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-04 | 196 | 27 | 3 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-04 | 196 | 27 | 3 | a7adc0e0baef261d0937e4e8351321d41beca82f | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.20e-04 | 196 | 27 | 3 | 6ba02b806d440eed45bad7616bf3b8be57034427 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.20e-04 | 196 | 27 | 3 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.20e-04 | 196 | 27 | 3 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-04 | 196 | 27 | 3 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-04 | 196 | 27 | 3 | 4bdc304c0c9d8bebe1a6a8a27e44acd1e8113725 | |
| ToppCell | PND07-Mesenchymal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-04 | 196 | 27 | 3 | 0050c7134473fbfd7b9f0ae8d6d337713e60b57d | |
| ToppCell | MatrixFB|World / shred on cell class and cell subclass (v4) | 2.24e-04 | 197 | 27 | 3 | e325de44e32021a36fffb7b7e88167b46bb051c7 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.24e-04 | 197 | 27 | 3 | 7290f05d0b8465637420119941bcbf2fae44a7e4 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-04 | 197 | 27 | 3 | 398a66c06df63567b176ab2cc85e27837e94d0d9 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-04 | 197 | 27 | 3 | 9af431323da6d099459b7360af40e5df998cffbd | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-04 | 197 | 27 | 3 | 888f3b14133e078570ce4ad73d9a9ee3137f9cac | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.24e-04 | 197 | 27 | 3 | 31dfd9842410b5c629f39b5130233995dceb0aef | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.24e-04 | 197 | 27 | 3 | 78122e1fb80e0ac3084dd4f7c551996330a701df | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.24e-04 | 197 | 27 | 3 | 106b0f9a0425facc634feb7498c9ba2c55edfbf8 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.24e-04 | 197 | 27 | 3 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 197 | 27 | 3 | b0e2ea81308bce289cb7cbea0e27de1d01afeed2 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-04 | 197 | 27 | 3 | fc718a254bda4df2d62975d04393492fb75ab305 | |
| ToppCell | systemic_lupus_erythematosus-treated|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.27e-04 | 198 | 27 | 3 | 8165ff735095c52994fb5057d89be93cc378b7da | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.27e-04 | 198 | 27 | 3 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 198 | 27 | 3 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Early_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.27e-04 | 198 | 27 | 3 | ecf0a8f2e07f336e23b6f32a2c48d3c7eb66572b | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-04 | 198 | 27 | 3 | a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8 | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.27e-04 | 198 | 27 | 3 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 198 | 27 | 3 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-04 | 198 | 27 | 3 | a1c8e5c332336823c47c04e56b6d7bc8f057c9da | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 198 | 27 | 3 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| Computational | Neighborhood of ACTG1 | 2.76e-05 | 124 | 16 | 4 | GCM_ACTG1 | |
| Computational | Neighborhood of DDX5 | 1.12e-04 | 65 | 16 | 3 | GCM_DDX5 | |
| Computational | RNA splicing. | 1.12e-04 | 65 | 16 | 3 | MODULE_183 | |
| Computational | Neighborhood of CUL1 | 1.52e-04 | 72 | 16 | 3 | MORF_CUL1 | |
| Computational | Neighborhood of PSME1 | 2.48e-04 | 85 | 16 | 3 | GCM_PSME1 | |
| Computational | Neighborhood of APEX1 | 5.88e-04 | 114 | 16 | 3 | GCM_APEX1 | |
| Computational | Neighborhood of NPM1 | 6.19e-04 | 116 | 16 | 3 | GCM_NPM1 | |
| Computational | Neighborhood of HDAC2 | 6.40e-04 | 280 | 16 | 4 | MORF_HDAC2 | |
| Computational | Neighborhood of PPP2CA | 8.44e-04 | 129 | 16 | 3 | MORF_PPP2CA | |
| Computational | Neighborhood of AP3D1 | 8.63e-04 | 130 | 16 | 3 | MORF_AP3D1 | |
| Computational | Neighborhood of GNB1 | 8.83e-04 | 305 | 16 | 4 | MORF_GNB1 | |
| Computational | Neighborhood of RFC4 | 1.33e-03 | 151 | 16 | 3 | MORF_RFC4 | |
| Computational | Neighborhood of RAD21 | 1.34e-03 | 37 | 16 | 2 | GCM_RAD21 | |
| Computational | Neighborhood of RAD23A | 1.44e-03 | 348 | 16 | 4 | MORF_RAD23A | |
| Computational | Neighborhood of RAF1 | 1.81e-03 | 43 | 16 | 2 | GCM_RAF1 | |
| Computational | Neighborhood of RAD21 | 2.20e-03 | 180 | 16 | 3 | MORF_RAD21 | |
| Computational | Neighborhood of DENR | 2.54e-03 | 51 | 16 | 2 | GNF2_DENR | |
| Computational | Neighborhood of RTN1 | 2.64e-03 | 52 | 16 | 2 | GNF2_RTN1 | |
| Computational | Neighborhood of AATF | 3.37e-03 | 209 | 16 | 3 | MORF_AATF | |
| Computational | Neighborhood of RAC1 | 3.50e-03 | 212 | 16 | 3 | MORF_RAC1 | |
| Computational | Neighborhood of RPA1 | 3.61e-03 | 61 | 16 | 2 | MORF_RPA1 | |
| Computational | Neighborhood of MSH2 | 3.61e-03 | 61 | 16 | 2 | MORF_MSH2 | |
| Computational | Neighborhood of SMC1L1 | 3.73e-03 | 62 | 16 | 2 | MORF_SMC1L1 | |
| Computational | Neighborhood of SART1 | 3.85e-03 | 63 | 16 | 2 | MORF_SART1 | |
| Computational | Neighborhood of TERF1 | 4.34e-03 | 67 | 16 | 2 | MORF_TERF1 | |
| Computational | Neighborhood of XRCC5 | 4.68e-03 | 235 | 16 | 3 | MORF_XRCC5 | |
| Computational | Neighborhood of UBE2I | 4.85e-03 | 238 | 16 | 3 | MORF_UBE2I | |
| Computational | Neighborhood of CDK2 | 5.00e-03 | 72 | 16 | 2 | MORF_CDK2 | |
| Computational | Neighborhood of NPM1 | 5.00e-03 | 72 | 16 | 2 | GNF2_NPM1 | |
| Computational | Genes in the cancer module 32. | 5.02e-03 | 241 | 16 | 3 | MODULE_32 | |
| Computational | Neighborhood of XRCC5 | 5.41e-03 | 75 | 16 | 2 | GNF2_XRCC5 | |
| Computational | Neighborhood of UNG | 5.55e-03 | 76 | 16 | 2 | MORF_UNG | |
| Computational | Neighborhood of HDAC1 | 5.81e-03 | 254 | 16 | 3 | MORF_HDAC1 | |
| Computational | Neighborhood of SP3 | 5.99e-03 | 79 | 16 | 2 | MORF_SP3 | |
| Computational | Neighborhood of DEK | 6.47e-03 | 264 | 16 | 3 | MORF_DEK | |
| Computational | Neighborhood of PRDX3 | 6.90e-03 | 85 | 16 | 2 | MORF_PRDX3 | |
| Computational | Neighborhood of BUB3 | 7.39e-03 | 277 | 16 | 3 | MORF_BUB3 | |
| Computational | Neighborhood of APEX1 | 8.04e-03 | 92 | 16 | 2 | GNF2_APEX1 | |
| Computational | Transcription. | 8.73e-03 | 96 | 16 | 2 | MODULE_124 | |
| Computational | Neighborhood of CSNK2B | 9.26e-03 | 99 | 16 | 2 | GCM_CSNK2B | |
| Computational | Genes in the cancer module 182. | 9.45e-03 | 100 | 16 | 2 | MODULE_182 | |
| Computational | Neighborhood of RRM1 | 9.81e-03 | 102 | 16 | 2 | MORF_RRM1 | |
| Computational | Neighborhood of PAPSS1 | 1.00e-02 | 103 | 16 | 2 | MORF_PAPSS1 | |
| Disease | myopathy (implicated_via_orthology) | 5.89e-10 | 48 | 26 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.62e-07 | 145 | 26 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | 2.24e-06 | 3 | 26 | 2 | cv:C1833662 | |
| Disease | INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA | 2.24e-06 | 3 | 26 | 2 | C1833662 | |
| Disease | autosomal dominant limb-girdle muscular dystrophy type 3 (implicated_via_orthology) | 1.12e-05 | 6 | 26 | 2 | DOID:0110306 (implicated_via_orthology) | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 3.51e-04 | 157 | 26 | 3 | DOID:224 (biomarker_via_orthology) | |
| Disease | cardioembolic stroke | 4.43e-04 | 170 | 26 | 3 | EFO_1001976 | |
| Disease | personality trait | 5.42e-04 | 39 | 26 | 2 | EFO_0004365 | |
| Disease | chronotype measurement | 9.20e-04 | 882 | 26 | 5 | EFO_0008328 | |
| Disease | information processing speed, response to cranial radiation therapy | 1.20e-03 | 58 | 26 | 2 | EFO_0004363, EFO_0010950 | |
| Disease | Amyotrophic Lateral Sclerosis | 1.20e-03 | 58 | 26 | 2 | C0002736 | |
| Disease | migraine disorder, endometriosis | 1.89e-03 | 73 | 26 | 2 | EFO_0001065, MONDO_0005277 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.30e-03 | 301 | 26 | 3 | DOID:684 (is_marker_for) | |
| Disease | erosive tooth wear measurement | 2.85e-03 | 90 | 26 | 2 | EFO_0009331 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AFGSSQMYSNNFGPN | 1916 | Q8TDI0 | |
| QMYSNNFGPNFRGPG | 1921 | Q8TDI0 | |
| NLNGMFYTAGQNHGK | 456 | Q15389 | |
| TSLQNQMNGGPFYSQ | 381 | Q9NYB9 | |
| YNNQSSNFGPMKGGN | 266 | Q32P51 | |
| YNNQSSNFGPMKGGN | 221 | A0A2R8Y4L2 | |
| NPSQQQFMQFGGSSG | 351 | Q8IUH3 | |
| YNRGGMPNRGNYNQN | 771 | Q00839 | |
| QQGYNAMGFSQGGQF | 106 | P50897 | |
| GGKFFNPFSNNMASQ | 276 | P36382 | |
| NPNGNGGFMGYSAEN | 506 | Q16526 | |
| QQGFSGGQGPYQAMS | 846 | Q86UU0 | |
| AQFNGKGSYGNGGAM | 141 | Q9NX46 | |
| NFNGSAGTPVMFNKN | 456 | Q14831 | |
| AFGNYMNGGNKTRGQ | 1496 | Q9NZ56 | |
| MAQGNNYGQTSNGVA | 1 | P49802 | |
| NGLNANMGFQTSGFN | 771 | Q6P3W7 | |
| SLQMGYTQGANQSGQ | 246 | Q99439 | |
| YNQQPSNYGPMKSGN | 306 | P22626 | |
| NYGQSMSGGNGQAAN | 406 | Q8WU79 | |
| MGFGYSLPDQNKGNN | 1031 | Q9HCK4 | |
| SGQQQSNYGPMKGGS | 336 | P51991 | |
| ETMPGGNNALGQNYA | 261 | Q8IYU4 | |
| QYGAMGAGQSFNSQF | 181 | Q8NF64 | |
| INNGNSSGMKPGQFN | 146 | Q9BY31 | |
| MLKFGSNGEGNGQFN | 656 | Q9C040 | |
| GNYNNQSSNFGPMKG | 316 | P09651 | |
| GNPQQYGQYMANGWQ | 301 | Q01085 |